These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17671259)

  • 21. Prophylactic progesterone to prevent preterm birth.
    Tita AT; O'Day MP
    Am J Obstet Gynecol; 2004 Jun; 190(6):1799-800; author reply 1801-2. PubMed ID: 15290820
    [No Abstract]   [Full Text] [Related]  

  • 22. [First year experience using arabin cervical pessary with intravaginal micronized progesterone for the prevention of preterm birth in patients with mid-trimester short cervix].
    Zimerman AL; Neeman O; Wiener Y; Maymon R; Arie H
    Harefuah; 2014 Feb; 153(2):79-82, 127. PubMed ID: 24716423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17 OHPC for prevention of preterm birth in twins: back to the drawing board?
    Durnwald CP
    Am J Obstet Gynecol; 2013 Mar; 208(3):167-8. PubMed ID: 23433323
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaginal progesterone in women with twin gestations complicated by short cervix: a retrospective cohort study.
    Brubaker SG; Pessel C; Zork N; Gyamfi-Bannerman C; Ananth CV
    BJOG; 2015 Apr; 122(5):712-8. PubMed ID: 25428801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 17-hydroxyprogesterone caproate, progesterone, preterm birth prevention, and safety: who decides? Someone should.
    O'Brien JM
    Am J Obstet Gynecol; 2011 May; 204(5):e16-7; author reply e17. PubMed ID: 21276949
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical management of the short cervix.
    Mateus J
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):367-85, xi-xii. PubMed ID: 21575806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Action of a natural progesterone associated with a synthetic progestogen and vitamin E in the treatment of threatened abortion and premature labor].
    Panariello S
    Arch Ostet Ginecol; 1970 Dec; 75(6):492-506. PubMed ID: 5526026
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of preterm birth by progestational agents: what are the molecular mechanisms?
    Nold C; Maubert M; Anton L; Yellon S; Elovitz MA
    Am J Obstet Gynecol; 2013 Mar; 208(3):223.e1-7. PubMed ID: 23433326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous Preterm Birth in Multiples.
    Biggio JR; Anderson S
    Clin Obstet Gynecol; 2015 Sep; 58(3):654-67. PubMed ID: 26083129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.
    Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella
    Am J Obstet Gynecol; 2012 May; 206(5):376-86. PubMed ID: 22542113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why the United States preterm birth rate is declining.
    Schoen CN; Tabbah S; Iams JD; Caughey AB; Berghella V
    Am J Obstet Gynecol; 2015 Aug; 213(2):175-80. PubMed ID: 25511243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-analysis of the PREGNANT trial confirms that vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix.
    McKay LA; Holford TR; Bracken MB
    Ultrasound Obstet Gynecol; 2014 May; 43(5):596-7. PubMed ID: 24585456
    [No Abstract]   [Full Text] [Related]  

  • 33. Author's reply: To PMID 25209926.
    Norwitz ER
    BJOG; 2015 Feb; 122(3):447-8. PubMed ID: 25623584
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials.
    Martinez de Tejada B; Karolinski A
    Am J Obstet Gynecol; 2015 Sep; 213(3):438-9. PubMed ID: 26003056
    [No Abstract]   [Full Text] [Related]  

  • 35. Reply: To PMID 25797233.
    Saccone G; Suhag A; Berghella V
    Am J Obstet Gynecol; 2015 Sep; 213(3):439-40. PubMed ID: 26003064
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolonged progesterone administration is associated with less frequent cervicovaginal colonization by Ureaplasma urealyticum during pregnancy - Results of a pilot study.
    Koucký M; Malíčková K; Cindrová-Davies T; Smíšek J; Vráblíková H; Černý A; Šimják P; Slováčková M; Pařízek A; Zima T
    J Reprod Immunol; 2016 Aug; 116():35-41. PubMed ID: 27172838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 17-α hydroxyprogesterone caproate for the prevention of preterm birth.
    Gupta S; Roman AS
    Womens Health (Lond); 2012 Jan; 8(1):21-30. PubMed ID: 22171770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Short Cervix during Pregnancy: A Review.
    Gilner J; Biggio J
    Am J Perinatol; 2016 Feb; 33(3):245-52. PubMed ID: 26788787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP.
    Armstrong J
    N Engl J Med; 2011 May; 364(18):1689-91. PubMed ID: 21410391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.